{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T07:44:03Z","timestamp":1708415043322},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T00:00:00Z","timestamp":1422144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00106-014-2966-6","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T17:36:10Z","timestamp":1422034570000},"page":"315-326","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aktuelle Aspekte zur Ototoxizit\u00e4t"],"prefix":"10.1007","volume":"63","author":[{"given":"L.E.","family":"Walther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"H\u00fclse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,25]]},"reference":[{"key":"2966_CR1","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/WNL.0b013e3181bacf85","volume":"73","author":"MacDougall","year":"2009","unstructured":"MacDougall HG, Weber KP, McGarvie LA et al (2009) The video head impulse test: diagnostic accuracy in peripheral vestibulopathy. Neurology 73:1134\u20131141","journal-title":"Neurology"},{"key":"2966_CR2","first-page":"168391","volume":"2013","author":"Walther","year":"2013","unstructured":"Walther LE, Huelse R, Bl\u00e4ttner K et al (2013) Dynamic change of VOR and otolith function in intratympanic gentamicin treatment for M\u00e9ni\u00e8re\u2019s disease: case report and review of the literature. Case Rep Otolaryngol 2013(1):168391","journal-title":"Case Rep Otolaryngol"},{"key":"2966_CR3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/03005368209081451","volume":"16","author":"Stephens","year":"1982","unstructured":"Stephens SD (1982) Some historical aspects of ototoxicity. Br J Audiol 16:76\u201380","journal-title":"Br J Audiol"},{"key":"2966_CR4","first-page":"305","volume":"Otorhinolaryngo","author":"Spoendlin","year":"1966","unstructured":"Spoendlin H (1966) Zur Ototoxizit\u00e4t des Streptomyzins. Pract Otorhinolaryngol (Basel) 28:305\u2013322","journal-title":"Pract"},{"key":"2966_CR5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0196-0709(91)90071-M","volume":"12","author":"Boettcher","year":"1991","unstructured":"Boettcher FA, Richard JS (1991) Salicylate ototoxicity: review and synthesis. Am J Otolaryngol 12:33\u201347","journal-title":"Am J Otolaryngol"},{"key":"2966_CR6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1152\/jn.00160.2004","volume":"93","author":"Hirvonen","year":"2005","unstructured":"Hirvonen TP, Minor LB, Hullar TE, Carey JP (2005) Effects of intratympanic gentamicin on vestibular afferents and hair cells in the chinchilla. J Neurophysiol 93:643\u2013655","journal-title":"J Neurophysiol"},{"key":"2966_CR7","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/0006-2952(95)02160-4","volume":"50","author":"Priuska","year":"1995","unstructured":"Priuska EM, Schacht J (1995) Formation of free radicals by gentamicin and iron and evidence for an iron\/gentamicin complex. Biochem Pharmacol 50:1749\u20131752","journal-title":"Biochem Pharmacol"},{"key":"2966_CR8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0030-6665(20)30764-7","volume":"26","author":"Monsell","year":"1993","unstructured":"Monsell EM, Cass SP, Rybak LP (1993) Therapeutic use of Aminoglycosides in M\u00e9ni\u00e8re\u2019s disease. Otolaryngol Clin North Am 26:737","journal-title":"Otolaryngol Clin North Am"},{"key":"2966_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1288\/00005537-198010001-00001","volume":"90","author":"Fee","year":"1980","unstructured":"Fee WE (1980) Aminoglykoside ototoxicity in the human. Laryngoscope 90:1\u201319","journal-title":"Laryngoscope"},{"key":"2966_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/149.1.23","volume":"149","author":"Moore","year":"1984","unstructured":"Moore RD, Smith CR, Lietman PS (1984) Risk factors for the development of auditory toxicity in patients receiving Aminoglycosides. J Infect Dis 149:23\u201330","journal-title":"J Infect Dis"},{"key":"2966_CR11","doi-asserted-by":"crossref","unstructured":"Federspil P (1982) Ototoxizit\u00e4t von Antibiotika unter besonderer Ber\u00fccksichtigung der Lokalbehandlung. In: Ganz H, Sch\u00e4tzle W (Hrsg) HNO Praxis Heute 2. Springer, Berlin","DOI":"10.1007\/978-3-642-68199-8_1"},{"key":"2966_CR12","first-page":"417","volume":"32","author":"Federspil","year":"1984","unstructured":"Federspil P (1984) Ototoxizit\u00e4ts-Grenzdosen. HNO 32:417\u2013418","journal-title":"HNO"},{"key":"2966_CR13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s00106-003-0994-8","volume":"52","author":"Kupka","year":"2004","unstructured":"Kupka S, Bodden-Kamps B, Baur M, Zenner HP (2004) Mitochondriale A1555g-Mutation. HNO 52:968\u2013972","journal-title":"HNO"},{"key":"2966_CR14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0793-289","volume":"4","author":"Prezant","year":"1993","unstructured":"Prezant TR, Agapian JV, Bohlman MC et al (1993) Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289\u2013294","journal-title":"Nat Genet"},{"key":"2966_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/VES-2008-18106","volume":"18","author":"Roth","year":"2008","unstructured":"Roth SM, Williams SM, Jiang L et al (2008) Susceptibility genes for gentamicin-induced vestibular dysfunction. J Vestib Res 18:59\u201368","journal-title":"J Vestib Res"},{"key":"2966_CR16","unstructured":"M\u00fcller K (2005) Untersuchungen zur beidseitigen Vestibularissch\u00e4digung (Bilaterale Vestibulopathie). Dissertation Friedrich Schiller-Universit\u00e4t Jena. http:\/\/www.db-thueringen.de\/servlets\/DerivateServlet\/Derivate-7580\/Mueller\/Diss.pdf"},{"key":"2966_CR17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ana.21105","volume":"61","author":"Zingler","year":"2007","unstructured":"Zingler VC, Cnyrim C, Jahn K et al (2007) Causative factors and epidemiology of bilateral vestibulopathy in 255 patients. Ann Neurol 61:524\u2013532","journal-title":"Ann Neurol"},{"key":"2966_CR18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/00016487709123943","volume":"84","author":"Harada","year":"1977","unstructured":"Harada Y, Sugimoto Y (1977) Metabolic disorder of otoconia after streptomycin intoxication. Acta Otolaryngol 84:65\u201371","journal-title":"Acta Otolaryngol"},{"key":"2966_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/00016488009127155","volume":"89","author":"Johnsson","year":"1980","unstructured":"Johnsson LG, Wright CG, Preston RE, Henry PJ (1980) Streptomycin-induced defects of the otoconial membrane. Acta Otolaryngol 89:401\u2013406","journal-title":"Acta Otolaryngol"},{"key":"2966_CR20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/00016489.2013.849384","volume":"134","author":"Walther","year":"2014","unstructured":"Walther LE, Wenzel A, Buder J et al (2014) Gentamicin-induced structural damage of human and artificial (biomimetic) otoconia. Acta Otolaryngol 134:111\u2013117","journal-title":"Acta Otolaryngol"},{"key":"2966_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00129492-200405000-00025","volume":"25","author":"Black","year":"2004","unstructured":"Black FO, Pesznecker SC, Homer L, Stallings V (2004) Benign paroxysmal positional nystagmus in hospitalized subjects receiving ototoxic medications. Otol Neurotol 25:353\u2013358","journal-title":"Otol Neurotol"},{"key":"2966_CR22","doi-asserted-by":"crossref","first-page":"e102516","DOI":"10.1371\/journal.pone.0102516","volume":"9","author":"Walther","year":"2014","unstructured":"Walther LE, Bl\u00f6dow A, Buder J, Kniep R (2014) Principles of calcite dissolution in human and artificial otoconia. PLoS One 9(7):e102516","journal-title":"PLoS One"},{"key":"2966_CR23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00106-004-1065-5","volume":"52","author":"Wecker","year":"2004","unstructured":"Wecker H, Laubert A (2004) Reversible H\u00f6rminderung bei akuter Salizylatintoxikation. HNO 52:347\u2013351","journal-title":"HNO"},{"key":"2966_CR24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/00016489509139302","volume":"115","author":"Jung","year":"1995","unstructured":"Jung TTK, Hwang AL, Miller SK et al (1995) Effect of leukotriene inhibitor on cochlear blood flow in salizylate ototoxicity. Acta Otolaryngol 115:251\u2013254","journal-title":"Acta Otolaryngol"},{"key":"2966_CR25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s11064-011-0455-9","volume":"36","author":"Feng","year":"2011","unstructured":"Feng H, Yin SH, Tang AZ, Tan SH (2011) Salizylate initiates apoptosis in the spiral anglgion euronn of guinea pig cochlea by activating caspase-3. Neurochem Res 36:1108\u20131115","journal-title":"Neurochem Res"},{"key":"2966_CR26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2165\/00002018-199309020-00006","volume":"9","author":"Brien","year":"1993","unstructured":"Brien JA (1993) Ototoxicity associated with salicylates. Drug Saf 9:143\u2013148","journal-title":"Drug Saf"},{"key":"2966_CR27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJM196509092731104","volume":"273","author":"Myers","year":"1965","unstructured":"Myers EN, Bernstein JM, Fostiropolous G (1965) Salicylate ototoxicity: a clinical study. N Engl J Med 273:587\u2013590","journal-title":"N Engl J Med"},{"key":"2966_CR28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.1989.tb03562.x","volume":"28","author":"Day","year":"1989","unstructured":"Day RO, Graham GG, Bieri D et al (1989) Concentration response relationships for salizylate-induced ototoxicity in normal volunteers. Br J Clin Pharmacol 28:695\u2013702","journal-title":"Br J Clin Pharmacol"},{"key":"2966_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amjmed.2009.08.006","volume":"123","author":"Curhan","year":"2010","unstructured":"Curhan SG, Eavey R, Shargorodsky J, Curhan GC (2010) Analgesic use and the risk of hearing loss in men. Am J Med 123:231\u2013237","journal-title":"Am J Med"},{"key":"2966_CR30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.1999.tb00278.x","volume":"884","author":"Humes","year":"1999","unstructured":"Humes HD (1999) Insights into ototoxicity. Analogies to nephrotoxicity. Ann N Y Acad Sci 884:15","journal-title":"Ann N Y Acad Sci"},{"key":"2966_CR31","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","volume":"26","author":"Rybak","year":"1993","unstructured":"Rybak LP (1993) Ototoxicity of loop diuretics. Otolaryngol Clin North Am 26:829","journal-title":"Otolaryngol Clin North Am"},{"key":"2966_CR32","doi-asserted-by":"crossref","unstructured":"Wangemann P, Schacht J (1996) Homeostatic mechanisms in the cochlea. In: The Cochlea. Springer, Berlin, S\u00a0130\u2013185","DOI":"10.1007\/978-1-4612-0757-3_3"},{"key":"2966_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(02)00585-3","volume":"173","author":"Ding","year":"2002","unstructured":"Ding D, McFadden SL, Woo JM, Salvi RJ (2002) Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea. Hear Res 173:1\u20139","journal-title":"Hear Res"},{"key":"2966_CR34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","volume":"34","author":"Langer","year":"2013","unstructured":"Langer T, am Zehnhoff-Dinnesen A, Radtke S et al (2013) Understanding platinum-induced ototoxicity. Trends Pharmacol Sci 34:458\u2013469","journal-title":"Trends Pharmacol Sci"},{"key":"2966_CR35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0773.1995.tb00167.x","volume":"76","author":"Ravi","year":"1995","unstructured":"Ravi R, Somani SM, Rybak LP (1995) Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 76:386\u2013394","journal-title":"Pharmacol Toxicol"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-014-2966-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00106-014-2966-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-014-2966-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T11:55:59Z","timestamp":1651060559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00106-014-2966-6"}},"subtitle":["Ototoxische Substanzen und deren Effekte"],"short-title":[],"issued":{"date-parts":[[2015,1,25]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["2966"],"URL":"https:\/\/doi.org\/10.1007\/s00106-014-2966-6","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,25]]}}}